Controlled Drug Release Systems for Cerebrovascular Diseases

Abstract This review offers a comprehensive exploration of optimized drug delivery systems tailored for controlled release and their crucial role in addressing cerebrovascular diseases. Through an in‐depth analysis, various controlled release methods, including nanoparticles, liposomes, hydrogels, and other emerging technologies are examined. Highlighting the importance of precise drug targeting, it is delved into the underlying mechanisms of these delivery systems and their potential to improve therapeutic outcomes while minimizing adverse effects. Additionally, the specific applications of these optimized drug delivery systems in treating cerebrovascular disorders such as ischemic stroke, cerebral aneurysms, and intracranial hemorrhage are discussed. By shedding light on the advancements in drug delivery techniques and their implications in cerebrovascular medicine, this review offers valuable insights into the future of therapeutic interventions in neurology.

Authors

Institutions

Publication Details

Journal
Advanced Therapeutics
Published
2024-10-08
DOI
https://doi.org/10.1002/adtp.202400239
Citations
3
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Controlled Drug Release Systems for Cerebrovascular Diseases

María Victoria Gómez‐Gaviro, Sofia Caspani, C. T. Sousa, Manuel Desco et al.
3 citations
Advanced Therapeutics
Nanoparticle-Based Drug Delivery
0.52
article

Controlled Drug Release Systems for Cerebrovascular Diseases

María Victoria Gómez‐Gaviro, Sofia Caspani, C. T. Sousa, Manuel Desco, Celia Martín‐Morales
article en
3 citations

Abstract

Abstract This review offers a comprehensive exploration of optimized drug delivery systems tailored for controlled release and their crucial role in addressing cerebrovascular diseases. Through an in‐depth analysis, various controlled release methods, including nanoparticles, liposomes, hydrogels, and other emerging technologies are examined. Highlighting the importance of precise drug targeting, it is delved into the underlying mechanisms of these delivery systems and their potential to improve therapeutic outcomes while minimizing adverse effects. Additionally, the specific applications of these optimized drug delivery systems in treating cerebrovascular disorders such as ischemic stroke, cerebral aneurysms, and intracranial hemorrhage are discussed. By shedding light on the advancements in drug delivery techniques and their implications in cerebrovascular medicine, this review offers valuable insights into the future of therapeutic interventions in neurology.

Advanced TherapeuticsVol. 8(1)
Universidade do Porto (PT), Spanish National Centre for Cardiovascular Research (ES), Hospital General Universitario Gregorio Marañón (ES), Centro de Investigación Biomédica en Red de Salud Mental (ES), Universidad Carlos III de Madrid (ES), Universidad Autónoma de Madrid (ES)
Comunidad de Madrid, Centro Nacional de Investigaciones Cardiovasculares, Agencia Estatal de Investigación
Good health and well-being
Openalex Percentile: Top 38%
Nanoparticle-Based Drug Delivery
0.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Controlled Drug Release Systems for Cerebrovascular Diseases — María Victoria Gómez‐Gaviro, Sofia Caspani, et al. · Advanced Therapeutics (2024) | TGRS Research Map | TGRS